Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07351435

The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique

The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing VV, VA or VAV ECMO implantation in the French West Indies and Guiana. All patients undergoing ECMO implantation will be prospectively registered.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

In the Caribbean region, access to advanced cardiac interventions faces difficulties owing to unequal distribution of health care resources, medical shortages and distance between health care centers in various islands.

At the University Hospital of Martinique (UHM) in Fort de France, a mobile ECMO team is available 24h a day, 7 days a week, for cardiopulmonary mechanical support in the French Overseas Territories and neighboring islands.

Implantation of veno-venous or veno-arterial (VV or VA) ECMO can be performed at the UHM or at remote hospitals. Some patients on VA-ECMO are transfered by airflight to the UHM and/or to French mainland whenever cardiac transplantation is indicated.

Since 2010, the ECMO-UHM database is a prospective event-driven registry housed and updated by the HeartTeam (perfusionnists, emergency and ICU physicians, cardiac surgeons, cardiothoracic anesthesiologists, cardiologists).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All consecutive patients implanted with a veno-venous extracorporeal membrane oxygenation device or extracorporeal membrane oxygenation device by the HeartTeam from the University Hospital of Martinique (UHM) from January 2010

Exclusion criteria

  • Patients with incomplete data (primary endpoint and less than 80% secondary study outcomes)

Treatment and study plan

Primary outcomes

  1. Mortality at 30 days

    Time frame: from canula implantation to 30 days afterwards

    Number of deceased participants as assessed at 30 days after ECMO implantation

Secondary outcomes

  1. Number of participants with major adverse events

    Time frame: From canula implantation to up to 6 months after ECMO implantation

    Major Adverse events (AE; numbers and rates) as assessed by the consensus statement of the mechanical circulatory support academic research consortium

Study contacts

Contact information is provided by the study sponsor or research team.

Jeremy MAZILE, BC perfusionnist

CONTACT

[email protected]

Marc LICKER, MD

CONTACT

[email protected]

+41796234488

Sponsors and collaborators

Lead sponsor

University of Genova

Other

Registry information

Important dates

Study start
2026
Primary completion
2032
Study completion
2033
First posted
Jan 20, 2026
Registry last updated
Jan 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.